In the BioHarmony Drug Report Database

"Preview" Icon

Atropine

Atropen, Atropine (atropine) is a small molecule pharmaceutical. Atropine was first approved as Atropen on 1982-01-01. It is used to treat bradycardia, heart arrest, poisoning, sinoatrial block, and stomach ulcer amongst others in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3, muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, muscarinic acetylcholine receptor M5, and muscarinic acetylcholine receptor M4. In addition, it is known to target alpha-2A adrenergic receptor.

 

Trade Name

 

Atropen, Atropine
 

Common Name

 

atropine
 

ChEMBL ID

 

CHEMBL517712
 

Indication

 

bradycardia, heart arrest, poisoning, sinoatrial block, stomach ulcer, uveitis
 

Drug Class

 

Atropine derivatives

Image (chem structure or protein)

Atropine structure rendering